Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
biotech
life sciences
national top stories
san francisco blog main
boston blog main
new york blog main
san francisco top stories
boston top stories
detroit blog main
detroit top stories
national
new york top stories
raleigh-durham blog main
san diego blog main
san diego top stories
wisconsin blog main
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
amgen
andrew oxtoby
arboretum ventures
aurora health care
babies
baird capital
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
cancer
cancer diagnostics
ceo
cholesterol
clinical hold
clinical study
clinical trials
combination
commissioner
What
medicine
5
×
week
5
×
announced
based
big
ceo
company
precision
aces
ann
arbor
area
bay
bio
biomedical
biopsy
bird
blood
bosley's
bosley’s
breakthroughs
bridge
bucks
buildout
cancer
cas
cholesterol
close
closed
conference
crime
crispr
departure
developing
diego’s
drug
early
editas
ending
exit
Language
unset
Current search:
xconomy.com
×
medicine
×
week
×
@xconomy.com
4 years ago
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round